Free Trial

CorVel (CRVL) Competitors

CorVel logo
$111.95 +0.42 (+0.38%)
Closing price 04:00 PM Eastern
Extended Trading
$111.96 +0.00 (+0.00%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRVL vs. LH, DGX, DVA, CHE, AMED, MD, AMN, CCRN, ERIE, and RYAN

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Erie Indemnity (ERIE), and Ryan Specialty (RYAN).

CorVel vs.

Laboratory Co. of America (NYSE:LH) and CorVel (NASDAQ:CRVL) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.

Laboratory Co. of America received 429 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 64.03% of users gave Laboratory Co. of America an outperform vote while only 63.61% of users gave CorVel an outperform vote.

CompanyUnderperformOutperform
Laboratory Co. of AmericaOutperform Votes
623
64.03%
Underperform Votes
350
35.97%
CorVelOutperform Votes
194
63.61%
Underperform Votes
111
36.39%

Laboratory Co. of America has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, CorVel has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

CorVel has a net margin of 10.12% compared to Laboratory Co. of America's net margin of 5.73%. CorVel's return on equity of 32.22% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
Laboratory Co. of America5.73% 15.29% 7.01%
CorVel 10.12%32.22%17.66%

In the previous week, Laboratory Co. of America had 5 more articles in the media than CorVel. MarketBeat recorded 15 mentions for Laboratory Co. of America and 10 mentions for CorVel. CorVel's average media sentiment score of 1.70 beat Laboratory Co. of America's score of 1.39 indicating that CorVel is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Laboratory Co. of America
12 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CorVel
9 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by company insiders. Comparatively, 47.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laboratory Co. of America$13.01B1.49$746M$8.8226.26
CorVel$871.31M6.60$76.25M$1.7065.85

Laboratory Co. of America currently has a consensus price target of $269.92, suggesting a potential upside of 16.52%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, equities analysts clearly believe Laboratory Co. of America is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86
CorVel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Laboratory Co. of America beats CorVel on 12 of the 19 factors compared between the two stocks.

Remove Ads
Get CorVel News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRVL vs. The Competition

MetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ Exchange
Market Cap$5.75B$19.56B$7.25B$8.06B
Dividend YieldN/A1.27%2.53%4.02%
P/E Ratio65.8526.5230.2919.03
Price / Sales6.605.86158.1593.17
Price / Cash57.1926.5531.5134.64
Price / Book19.1019.854.884.33
Net Income$76.25M$731.04M$195.43M$247.06M
7 Day Performance4.31%-1.48%0.39%-0.52%
1 Month Performance3.14%-1.97%-2.82%-3.73%
1 Year Performance29.87%5.63%6.12%1.74%

CorVel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRVL
CorVel
1.0998 of 5 stars
$111.95
+0.4%
N/A+30.3%$5.75B$871.31M65.854,230Positive News
LH
Laboratory Co. of America
4.7654 of 5 stars
$240.43
+0.4%
$268.38
+11.6%
+9.2%$20.12B$13.01B27.2675,500Positive News
DGX
Quest Diagnostics
4.837 of 5 stars
$173.62
+2.0%
$178.23
+2.7%
+29.4%$19.27B$9.87B22.5848,000Analyst Revision
DVA
DaVita
3.8552 of 5 stars
$149.22
+4.0%
$166.33
+11.5%
+11.9%$11.94B$12.82B13.8970,000Positive News
CHE
Chemed
4.5636 of 5 stars
$608.63
+1.7%
$667.00
+9.6%
-4.5%$8.91B$2.43B30.7515,087Positive News
AMED
Amedisys
3.1867 of 5 stars
$92.64
+0.1%
$100.75
+8.8%
+0.2%$3.04B$2.35B36.7620,000Positive News
MD
Pediatrix Medical Group
1.2495 of 5 stars
$14.26
+4.0%
$17.08
+19.8%
+53.9%$1.22B$2.01B-11.895,170Positive News
AMN
AMN Healthcare Services
4.3366 of 5 stars
$24.63
-7.9%
$41.17
+67.1%
-62.0%$940.60M$2.98B-6.403,585Analyst Upgrade
Positive News
CCRN
Cross Country Healthcare
3.7939 of 5 stars
$15.32
-1.7%
$18.41
+20.1%
-18.6%$502.70M$1.34B-306.342,700Short Interest ↓
ERIE
Erie Indemnity
2.2382 of 5 stars
$425.25
+0.9%
N/A+3.3%$19.64B$3.86B39.786,040
RYAN
Ryan Specialty
1.8833 of 5 stars
$71.33
+2.1%
$75.27
+5.5%
+29.3%$18.68B$2.52B103.384,350Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:CRVL) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners